Anthem Biosciences Limited IPO (ANTHEM)

Status
Listed
Security type
Mainboard
Price band
Rs.540 to Rs.570
Final issue price
Rs 570
Issue size
Not disclosed
Bidding opens
14 July 2025
Bidding closes
16 July 2025
Listing date
21 July 2025

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Anthem Biosciences Limited IPO?

The Anthem Biosciences Limited IPO price band is Rs.540 to Rs.570 per share.

When does the Anthem Biosciences Limited IPO open and close?

Bidding opens 14 July 2025 and closes 16 July 2025.

Is the Anthem Biosciences Limited IPO a mainboard or SME issue?

Anthem Biosciences Limited is a mainboard IPO, listing on NSE's main board.

When did the Anthem Biosciences Limited IPO list?

Anthem Biosciences Limited listed on 21 July 2025.

Does this page show the grey market premium (GMP) for Anthem Biosciences Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Anthem Biosciences Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.